Compare Aavas Financiers with Similar Stocks
Dashboard
With ROE of 13, it has a Expensive valuation with a 3 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -16.16%, its profits have risen by 13.1% ; the PEG ratio of the company is 1.8
54.05% of Promoter Shares are Pledged
Below par performance in long term as well as near term
Stock DNA
Housing Finance Company
INR 11,602 Cr (Small Cap)
23.00
12
0.00%
3.29
13.00%
3.04
Total Returns (Price + Dividend) 
Aavas Financiers for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Aavas Financiers Ltd: Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons
Aavas Financiers Ltd., a prominent player in the housing finance sector, has seen its valuation parameters shift markedly, with its price-to-earnings (P/E) and price-to-book value (P/BV) ratios moving into the 'very expensive' territory. This re-rating comes amid a backdrop of subdued stock performance relative to the broader market and peers, raising questions about the stock’s price attractiveness and investment appeal going forward.
Read full news article
Aavas Financiers Ltd. is Rated Sell
Aavas Financiers Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 January 2026, providing investors with an up-to-date view of the company's performance and outlook.
Read full news article
Aavas Financiers Ltd: Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons
Aavas Financiers Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating, driven primarily by its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical averages and peer benchmarks. This re-rating has prompted a downgrade in its MarketsMOJO Mojo Grade from Hold to Sell, reflecting increased caution among investors despite the company’s steady operational metrics.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
31-Jan-2026 | Source : BSEIntimation of Allotment under ESOPs and PSOPs scheme of the Company
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
20-Jan-2026 | Source : BSEPursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we hereby inform you that Company will hold an Earnings Conference Call on Thursday February 05 2026 at 05:30 P.M. (IST) to discuss with the investors/analysts the Financial and Operational Performance of the Company for the Quarter and Nine Months ended December 31 2025.
Board Meeting Intimation for Regulation 29 And 50 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015
20-Jan-2026 | Source : BSEAAVAS Financiers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the Quarter and Nine Months ended December 31 2025.
Corporate Actions 
05 Feb 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
54.0521
Held by 19 Schemes (9.18%)
Held by 156 FIIs (25.88%)
Aquilo House Pte. Ltd. (48.95%)
Axis Max Life Insurance Limited A/c Reversionary Bonus Participating - Equity (2.88%)
8.62%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 6.29% vs -1.36% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 17.74% vs -9.40% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 15.43% vs 16.41% in Sep 2024
Growth in half year ended Sep 2025 is 10.64% vs 18.40% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is 16.77% vs 26.98% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 20.79% vs 14.76% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 16.70% vs 25.44% in Mar 2024
YoY Growth in year ended Mar 2025 is 17.00% vs 14.10% in Mar 2024






